In a recent published report, Kenneth Research has updated the market report for U.S. Non-Invasive Prenatal Testing Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.
U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for U.S. Non-Invasive Prenatal Testing Market products.
Download Sample of This Strategic Report-: https://www.kennethresearch.com/sample-request-10166491
According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018. Moreover, growing concern for deaths caused due to various diseases and the need for treatment that can lower the crude death rate, which in the year 2019 recorded close to 7% (per 1000 people), are also anticipated to drive the market growth during the forecast period.
U.S. Non-Invasive Prenatal Testing Market in its database of market research reports which provides its readers an in-depth analysis on the latest trends, growth opportunities and growth drivers that are associated with the growth of the market. The report additionally shares critical insights on U.S. Non-Invasive Prenatal Testing Market, along with the compound growth rate (CAGR) of the market for a projected period between 2021 and 2027. The report also includes analysis of the market by utilizing different analytical tools, such as PESTEL analysis and Porter’s five forces analysis. These tools also provide an in-depth analysis on the micro and macro-environmental factors that are associated with the growth of the market during the forecast period.
Kenneth Research recently added a report on U.S. Non-Invasive Prenatal Testing Market in its database of market research reports which provides its readers an in-depth analysis on the latest trends, growth opportunities and growth drivers that are associated with the growth of the market. The report additionally shares critical insights on U.S. Non-Invasive Prenatal Testing Market, along with the compound growth rate (CAGR) of the market for a projected period between 2021 and 2027. The report also includes analysis of the market by utilizing different analytical tools, such as PESTEL analysis and Porter’s five forces analysis. These tools also provide an in-depth analysis on the micro and macro-environmental factors that are associated with the growth of the market during the forecast period.
The Centers for Medicare & Medicaid Services reported that the U.S health care spending grew 3.9% in 2017, reaching $3.5 trillion or $10,739 per person. This rise in healthcare expenditure across the nation is expected to boost the high-end healthcare diagnostic and treatment procedures and technologies, in-turn propelling the non-invasive prenatal testing market during the forecast period.
“The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).”
Download Sample of This Strategic Report-: https://www.kennethresearch.com/sample-request-10166491
The US holds around 84% of the market share of the NIPT market in North America majorly due to its dominating share in the healthcare industry in 2018. Presence of major market players across the U.S such as, Natera Inc., Illumina Inc., Laboratory Corporation of America Holdings and others are significantly influencing the non invasive prenatal testing market. The U.S NIPT market is expected to grow further on the back of growing research and development practices and expanding product applications with increasing discoveries.
Increasing incidences of chronic oncogenic diseases such as cancer with an estimated new cases of 18.1 million in 2018, as per International Agency for Research on Cancer (IARC), is anticipated to display rapid growth in application of Non-invasive Prenatal Testing in the upcoming years to diagnose irregular chromosome sequences of fetuses and calculate the probability of cancer incidence in the fetus over the future
NIPT provides an opportunity to detect more cases of fetal aneuploidies, with fewer invasive diagnostic procedures.
The method proven to have very high sensitivity and specificity for detecting common aneuploidies such as T21, T18, and T13, with low false positive and false negative rates is anticipated to contribute positively to NIPT market. Different scenarios for NIPT-based screening for common autosomal aneuploidies are possible depending on the health-care settings. National guidelines have recommended that all pregnant women be offered NIPT for aneuploidies. Positive cell-free fetal DNA tests need to be confirmed using invasive testing and with more accurate screening tests, this may reduce the need for invasive testing and associated morbidities.
Microdeletion is a submicroscopic deletion phenomenon leading to monosomy of a chromosomal segment too small to be detected by conventional cytogenetics, typically less than 5 megabases in size. There are many different types of microdeletions. There are many microdeletions which does not effect a baby’s health and development at all, but others can result in intellectual disability, problems such as motor skills, birth defects and miscarriage. Use of NIPT can help to take efficient steps to improve fetal health and quality of life by focusing on finding microdeletions that can affect a child’s physical and mental development.
The implementation of local government initiatives to provide safe and effective prenatal tests is increasing the demand for NIPT test in diagnostic labs. Rising incidences of chromosomal abnormalities is further creating an upsurge in demand for NIPT tests. Diagnostic labs for NIPT are being preferred by patients as they have all diagnostics instrument and proper physicians for conducting these tests.
“The Final Report will cover the impact analysis of COVID-19 on this industry.”
Download Sample of This Strategic Report-:
https://www.kennethresearch.com/sample-request-10166491
About Kenneth Research:
Kenneth Research provides market research reports to different individuals, industries, associations, and organizations with the aim of helping them to take prominent decisions. Our research library comprises more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both the macro level as well as micro-level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis of various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keeps a track of the international and domestic market for any economic changes impacting the products’ demand, growth, and opportunities for new and existing players.
Contact Us
Kenneth Research
Email: Sales@kennethresearch.com
Phone: +1 313 462 0609
————————New Related Reports——————————
Single Cell Genome Sequencing Market
Respiratory Drugs Global Market
Hydroxychloroquine Sulphate Global Market
Cancer Screening Global Market
